Skip to main content

PMC Search Update

PMC Beta search will replace the current PMC search the week of September 7, 2025. Try out PMC Beta search now and give us your feedback. Learn more

Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2006 Dec 16;284(1):239–246. doi: 10.1111/j.1749-6632.1977.tb21956.x

EFFECT OF RIBAVIRIN ON VIRAL HEPATITIS IN LABORATORY ANIMALS

Robert W Sidwell 1, John H Huffman 1, Nancy Campbell 1, Lois B Allen 1
PMCID: PMC7168005  PMID: 212975

The content is available as a PDF (335.7 KB).

References

  • 1. Dienhart, F. & Holmes A. W.. 1965. Epidemiology and etiology of viral hepatitis In Progress in Liver Diseases, Popper H. & Schaffner F., Eds. Vol. 2: 373 Grune, New York , N.Y. [Google Scholar]
  • 2. Sidwell, R. W. , Huffman J. H., Khare C. P., Allen L. B., Witkowski J. T. & Robins R. K.. 1972. Broad‐spectrum antiviral activity of Virazole: 1‐β‐D‐ribofuranosyl‐1,2,4‐triazole‐3‐carboxamide. Science 177: 705–706. [DOI] [PubMed] [Google Scholar]
  • 3. Witkowski, J. T. , Robins R. K., Sidwell R. W. & Simon L. N.. 1972. Design, synthesis and broad‐spectrum antiviral activity of 1‐β‐D‐ribofuranosyl‐1,2,4‐triazole‐3‐carboxamide and related and related nucleosides. J. Med.Chem. 15: 1150–1154. [DOI] [PubMed] [Google Scholar]
  • 4. Huffman, J. H. , Sidwell R. W., Khare G. P., Witkowski J. T., Allen L. B. & Robins R. K.. 1973. In vitro effect of 1‐β‐D‐ribofuranosyl‐1,2,4‐triazole‐3‐carboxamide (Virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob. Ag. Chemother. 3: 235–241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Simon, L. N. , Sidwell R. W., Khare G. P., Streeter D. G., Miller J. P., Witkowski J. T., Huffman J. H. & Robins R. K.. 1973. Molecular basis of antiviral chemotherapy: Virazole, a new broad‐spectrum antiviral agent In Virus Research, 2nd ICN‐UCFA Symposium on Molecular Biology, Fox C. F. and Robinson W. S., Eds.: 415–436. Academic Press, New York , N.Y. [Google Scholar]
  • 6. Sidwell, R. W. , Witkowski J. T. & Robins R. K.. 1974. Antiviral activity of Virazole: Review and structure‐activity relationships. 1974. Prog. Chemother., Proc. 8th Int. Congr. Chemother., Athens, Greece. 2: 889–903. [Google Scholar]
  • 7. Miller, J. P. , Streeter D. G., Robins R. K. & Simon L. N.. 1976. The relationship between the metabolism of ribavirin and its proposed mechanism of action. Ann. N.Y. Acad. Sci. This volume. [DOI] [PubMed]
  • 8. Braunsteiner, H. & Friend C.. 1954. Viral hepatitis associated with transplantable mouse leukemia. I. Acute hepatic manifestations following treatment with urethane or methylformamide. J. Exp. Med. 100: 665–677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Doll, E. R. , Bryans J. T., Mccollum W. H. & Crowe E. W.. 1956. Propagation of equine abortion virus in Syrian hamsters. Cornell Vet. 46: 68–82. [PubMed] [Google Scholar]
  • 10. Randall, C. C. & Bracken E. C.. 1957. Studies on hepatitis in hamsters infected with equine abortion virus. I. Sequential development of inclusion and growth cycle. Amer. J. Pathol. 33: 709–727. [PMC free article] [PubMed] [Google Scholar]
  • 11. Friend, C. , Wroblewski F. & La Due J. S.. 1955. Glutamic‐oxalacetic transaminase activity of serum in mice with viral hepatitis. J. Exp. Med. 102: 699–704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Sigma Technical Bulletin No. 505. Sigma Chemical Co., St. Louis, Mo.
  • 13. Nosslin, B. 1960. The direct direct diazo reaction of bile pigments in serum. Experimental and clinical studies. Scand. J. Clin. and Lab. Invest. 12(Suppl. 49):1–176. [Google Scholar]
  • 14. Cavallini, G. , Massarani E. & Nardi D.. 1964. Antiviral compounds. IX. Steroid derivatives. J. Med. Chem. 7: 673–675. [DOI] [PubMed] [Google Scholar]
  • 15. Anderson, E. L. , Casey J. E., Jr., E. E. Force. Jensen E. M., Matz R. S. & Rivard D. E.. 1966. Antiviral agents. II. Substituted morpholinium quaternary salts. J. Med. Chem. 9: 211–213. [DOI] [PubMed] [Google Scholar]
  • 16. Judah, J. D. , Bjotvedt G. & Vainio T.. 1960. Protection against liver injury due to murine hepatitis virus. Nature 187: 507–508. [DOI] [PubMed] [Google Scholar]
  • 17. Stone, R. L. , De Long D. C., Hull R. N. & Johnson I. S.. 1965. In vivo and in vitro hibition of hepatitis viruses by streptothricin. Ann. N.Y. Acad. Sci. 130: 355–364. [DOI] [PubMed] [Google Scholar]
  • 18. Lieberman, M. , Pascale A., Schafer T. W. & Came P. E.. 1972. Effect of antiviral agents in equine abortion virus‐infected hamsters. Antimicrob. Ag. Chemother. 1: 143–147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Allen, L. B. , Huffman J. H., Revankar G. R., Tolman R. L., Simon L. N., Robins R. K. & Sidwell R. W.. 1975. Efficacy of 9‐β‐D‐ribofuranosylhypoxanthine‐5′‐monophosphate in therapy of equine abortion virus‐induced hepatitis in hamsters. Antimicrob. Ag. Chemother. 8: 474–478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Streeter, D. G. , Witkowski J. T., Khare G. P., Sidwell R. W., Bauer R. J., Robins R. K. & Simon L. N.. 1973. Mechanism of action of 1‐β‐D‐ribofuranosyl‐1,2,4‐triazole‐3‐carboxamide (Virazole), a new broad‐spectrum antiviral agent. Proc. Nat. Acad. Sci. U.S.A. 70: 1174–1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Oxford, J. S. 1975. Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (ribavirin). J. Gen. Virol. 28: 409–414. [DOI] [PubMed] [Google Scholar]
  • 22. Zuniga, C. B. A. Almeida , Iervolino A. C. L., Castro I. O., & Galvao P. A. A.. 1974. Acao do l‐beta‐D‐ribofuranosyl‐1,2,4‐triazol‐3‐carboxamida no tratamento das hepatites virais agudas. Rev. Assoc. Med. Brasil 20: 386–390. [PubMed] [Google Scholar]
  • 23. Vilela, M. P. , Siqueira W. A., Domingues S. H. S., Rodrigues L. D. & Rodrigues F. S.. 1974. Comportamento do antigeno Australia nos casos de hepatite por virus tratados com o l‐beta‐D‐ribofuranosyl‐1,2,4‐triazol‐3‐carboxamide. Rev. Bras. Clin. Terap. 3: 27–28. [Google Scholar]

Articles from Annals of the New York Academy of Sciences are provided here courtesy of Wiley

RESOURCES